Hair Loss Linked To Taxotere. A number of women undergoing chemotherapy for breast cancer have recently come forward naming Taxotere (docetaxel) as a possible cause for their apparent permanent hair loss. Many have filed lawsuits against Taxotere’s manufacturer, Sanofi-Aventis. Patients are attracted to Taxotere as it is received … [Read more...]
Permanent Hair Loss Linked To Taxotere Breast Cancer Treatment
Questions about Sexual Side Effects of Hair-Loss Drug
A review of 34 clinical trials on a popular drug to treat hair loss in men found that none of the studies adequately reported on the drug’s sexual side effects. The findings raise serious questions about whether finasteride, marketed as Propecia and Proscar, among other names, is safe, according to the report by scientists at … [Read more...]
Acute Pancreatitis, Over-inflation Reported with Obesity Balloon Treatment
Acute Pancreatitis, Over-inflation Reported. Parker Waichman LLP is investigating potential lawsuits on behalf of individuals who suffered adverse events related to fluid-filled intragastric balloons, such as the Orbera Balloon System manufactured by Apollo Endo-Surgery and the ReShape Balloon System manufactured by ReShape Medical … [Read more...]
High-Dose Diflucan Risky in Early Pregnancy
High-Dose Diflucan Treatment. A Drug Safety Communication issued today by the U.S. Food & Drug Administration (FDA) warned that chronic use of high-dose (400-800 mg/day) Diflucan or generic fluconazole during early pregnancy might be associated with the development of certain rare birth defects. In the communication, the FDA … [Read more...]
Fracking Fluid Treatment Plant Proposal Raises Concerns in Pennsylvania
Cold Welcome For Proposed Fracking Fluid Treatment Facility. A proposed hydraulic fracturing water treatment facility is not getting a warm reception in one Northeastern Pennsylvania town. At a meeting before the Wysox Township Zoning Hearing Board last week to discuss the issue, some attendees expressed concerns about the impact the … [Read more...]
FDA Panel Rejects Seroquel As Depression Treatment
Seroquel As First-Line Depression Treatment. Last week, the U.S. Food and Drug Administration (FDA) announced that while AstraZeneca’s schizophrenia and bipolar disorder medication, Seroquel (quetiapine), can be taken to treat depression, there are side effect concerns that include the risk of a sudden cardiac death, reported the … [Read more...]
Late Treatment with Stents Questioned
Cardiac stents subject of much controversy in recent years. Cardiac stents have been the subject of much controversy in recent months and, now, two emerging studies have found that patients do not fare better over medications and other treatments than with stents following heart attacks. Stents are tiny wire-mesh tubes used to … [Read more...]
